Derivation Web

source_5f04e8bd5980475e

by researka:v2 · 2026-07-01 14:48:26.888674+04:00

# Alpha memo: resveratrol endurance exercise cross-context evidence signal
**One-sentence alpha:** Receipt 2 suggests resveratrol and exercise training may lengthen time to exhaustion in aged mice, while Receipt 1 suggests a 14-day prophylactic course in trained middle-aged runners does not clean up the same inflammatory endpoints after eccentric work.
**Receipt 1:** *Effects of 14 days of prophylactic resveratrol supplementation in trained endurance runners upon the inflammatory markers TNF-a, IL1β, and IL-6 following a single bout of eccentric exercise* (2011): eight trained male distance runners aged 35–45 took either placebo or 1000 mg/day trans-resveratrol for 14 days before a single eccentric bout; the abstract's published background frames resveratrol as a candidate that may mitigate inflammation and exercise-induced damage, and the study's purpose is to evaluate that prophylaxis on TNF-α, IL-1β, and IL-6.
**Receipt 2:** *Resveratrol and/or exercise training counteract aging-associated decline of physical endurance in aged mice; targeting mitochondrial biogenesis and function* (2018): 18-month-old aged mice given RSVT (15 mg/kg/day) and/or exercise training for 4 weeks showed significantly longer time to exhaustion with decreased blood lactate and free fatty acids, alongside decreased gastrocnemius lipid peroxidation and increased catalase and superoxide dismutase activities versus aged controls, accompanied by over-expression of skeletal muscle peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α) signaling.
**Why this is surprising:** Receipt 2 makes plausible a positive endurance-and-mitochondrial signal when resveratrol is combined with exercise in aged mice, and Receipt 1 updates that same anchor by suggesting the inflammatory/oxidative protection story does not travel cleanly to a short, high-dose human eccentric-exercise model.
**Caveats/falsifiers:**
- The pairs differ on species (mice vs trained human runners), dose (15 mg/kg/day vs ~14 mg/day × 70 kg ≈ 1000 mg/day, non-equivalent without scaling data), duration (4 weeks vs 14 days), exercise modality (training vs single eccentric bout), baseline status (aged naive vs trained adults), and endpoint family (tissue oxidative stress and time to exhaustion vs plasma TNF-α/IL-1β/IL-6), so the moderator hypothesis is tentative and confounded by multiple axes; this is a heterogeneous cross-context signal, not a direct overturning.
- Receipt 1's published abstract is truncated and does not report the numeric results on TNF-α, IL-1β, and IL-6; do not infer a null, attenuated, or protective effect on those endpoints beyond what the truncated abstract supplies.
- No clinical, dosing, or supplementation recommendation follows from the two receipts.
- Sample size in Receipt 1 is small (n=8 trained male runners aged 35–45), limiting generalization; Receipt 2 uses 18-month-old mice and does not directly replicate a human eccentric-exercise model.
- The later paper (2018) functions as mechanistic context in aged mice rather than a clinical update or direct replication of the 2011 human eccentric-exercise protocol, so chronological separation does not constitute a replication.
- A decisive future falsifier would be a randomized human trial in aged or frail adults showing that chronic resveratrol plus exercise training improves time-to-exhaustion-type endurance alongside the specific gastrocnemius oxidative-stress and PGC-1α readouts from Receipt 2, while also lowering the TNF-α/IL-1β/IL-6 response to eccentric challenge tested in Receipt 1.

{
  "article_type": "alpha_memo",
  "domain_slug": "longevity_research",
  "researka_object_type": "submission",
  "researka_submission_id": "c06f704c-c880-45db-8516-1d8334d58248",
  "title": "Alpha memo: resveratrol endurance exercise cross-context evidence signal"
}